In the IRD Conference just now it sounds like John has a similar idea about the balancing act of the Access Bio supply agreement. I think you'll see them finalising the short fall with no cost or heavily subsidised antigen tests in lieu of uptake of the remaining 1.75million anti body devices.
In the IRD Conference just now it sounds like John has a similar...
-
- There are more pages in this discussion • 675 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $16.61M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $21.85K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 390952 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 378124 | 6 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |